CD8 T cells are essential for recovery from a respiratory vaccinia virus infection

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2432-2440

  Goulding, John ^a,b   Bogue, Rebecka ^a   Tahiliani, Vikas ^a,b   Croft, Michael ^a   Salek Ardakani, Shahram ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; LYMPHOCYTE FUNCTION; MORTALITY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY VACCINIA VIRUS INFECTION; T CELL DEPLETION; VACCINIA; VACCINIA VIRUS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RECOVERY OF FUNCTION; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; VACCINIA; VACCINIA VIRUS;

EID: 84865409309     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200799     Document Type: Article

References (40)

1. Roberts, K. L., and G. L. Smith. 2008. Vaccinia virus morphogenesis and dissemination. Trends Microbiol. 16: 472-479.
2. Weinstein, R. S. 2011. Should remaining stockpiles of smallpox virus (variola) be destroyed? Emerg. Infect. Dis. 17: 681-683.
3. Henderson, D. A., T. V. Inglesby, J. G. Bartlett, M. S. Ascher, E. Eitzen, P. B. Jahrling, J. Hauer, M. Layton, J. McDade, M. T. Osterholm, et al; Working Group on Civilian Biodefense. 1999. Smallpox as a biological weapon: medical and public health management. JAMA 281: 2127-2137.
4. Rimoin, A. W., P. M. Mulembakani, S. C. Johnston, J. O. Lloyd Smith, N. K. Kisalu, T. L. Kinkela, S. Blumberg, H. A. Thomassen, B. L. Pike, J. N. Fair, et al. 2010. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. USA 107: 16262-16267.
5. Megid, J., I. A. Borges, J. S. Abrahão, G. S. Trindade, C. M. Appolinário, M. G. Ribeiro, S. D. Allendorf, J. M. Antunes, A. T. Silva-Fernandes, and E. G. Kroon. 2012. Vaccinia virus zoonotic infection, São Paulo State, Brazil. Emerg. Infect. Dis. 18: 189-191.
6. Breman, J. G., and I. Arita. 1980. The confirmation and maintenance of smallpox eradication. N. Engl. J. Med. 303: 1263-1273.
7. Xu, R., A. J. Johnson, D. Liggitt, and M. J. Bevan. 2004. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172: 6265-6271.
8. Spriggs, M. K., B. H. Koller, T. Sato, P. J. Morrissey, W. C. Fanslow, O. Smithies, R. F. Voice, M. B. Widmer, and C. R. Maliszewski. 1992. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA 89: 6070-6074.
9. Panchanathan, V., G. Chaudhri, and G. Karupiah. 2006. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J. Virol. 80: 6333-6338.
10. Panchanathan, V., G. Chaudhri, and G. Karupiah. 2008. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86: 80-86.
11. Belyakov, I. M., P. Earl, A. Dzutsev, V. A. Kuznetsov, M. Lemon, L. S. Wyatt, J. T. Snyder, J. D. Ahlers, G. Franchini, B. Moss, and J. A. Berzofsky. 2003. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc. Natl. Acad. Sci. USA 100: 9458-9463.
12. Williamson, J. D., R. W. Reith, L. J. Jeffrey, J. R. Arrand, and M. Mackett. 1990. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J. Gen. Virol. 71: 2761-2767.
13. Schriewer, J., R. M. Buller, and G. Owens. 2004. Mouse models for studying orthopoxvirus respiratory infections. Methods Mol. Biol. 269: 289-308.
14. Chapman, J. L., D. K. Nichols, M. J. Martinez, and J. W. Raymond. 2010. Animal models of orthopoxvirus infection. Vet. Pathol. 47: 852-870.
15. Briody, B. A. 1959. Response of mice to ectromelia and vaccinia viruses. Bacteriol. Rev. 23: 61-95.
16. Turner, G. S. 1967. Respiratory infection of mice with vaccinia virus. J. Gen. Virol. 1: 399-402.
17. Hayasaka, D., F. A. Ennis, and M. Terajima. 2007. Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses. Virol. J. 4: 22.
18. Reading, P. C., and G. L. Smith. 2003. A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J. Gen. Virol. 84: 1973-1983.
19. Nelson, J. B. 1938. The Behavior of Pox Viruses in the Respiratory Tract: I. The Response of Mice to the Nasal Instillation of Vaccinia Virus. J. Exp. Med. 68: 401-412.
20. Luker, K. E., M. Hutchens, T. Schultz, A. Pekosz, and G. D. Luker. 2005. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology 341: 284-300.
21. Martinez, J., X. Huang, and Y. Yang. 2010. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog. 6: e1000811.
22. Kawakami, Y., Y. Tomimori, K. Yumoto, S. Hasegawa, T. Ando, Y. Tagaya, S. Crotty, and T. Kawakami. 2009. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J. Exp. Med. 206: 1219-1225.
23. Lehmann, M. H., W. Kastenmuller, J. D. Kandemir, F. Brandt, Y. Suezer, and G. Sutter. 2009. Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression. J. Virol. 83: 2540-2552.
24. Sánchez-Puig, J. M., L. Sánchez, G. Roy, and R. Blasco. 2004. Susceptibility of different leukocyte cell types to Vaccinia virus infection. Virol. J. 1: 10.
25. Bonduelle, O., D. Duffy, B. Verrier, C. Combadière, and B. Combadière. 2012. Cutting edge: Protective effect of CX3CR1+ dendritic cells in a vaccinia virus pulmonary infection model. J. Immunol. 188: 952-956.
26. Salek-Ardakani, S., M. Moutaftsi, S. Crotty, A. Sette, and M. Croft. 2008. OX40 drives protective vaccinia virus-specific CD8 T cells. J. Immunol. 181: 7969-7976.
27. Salek-Ardakani, S., R. Flynn, R. Arens, H. Yagita, G. L. Smith, J. Borst, S. P. Schoenberger, and M. Croft. 2011. The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J. Clin. Invest. 121: 296-307.
28. Zhao, Y., C. De Trez, R. Flynn, C. F. Ware, M. Croft, and S. Salek-Ardakani. 2009. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus. J. Immunol. 182: 6278-6286.
29. Moutaftsi, M., H. H. Bui, B. Peters, J. Sidney, S. Salek-Ardakani, C. Oseroff, V. Pasquetto, S. Crotty, M. Croft, E. J. Lefkowitz, et al. 2007. Vaccinia virusspecific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses. J. Immunol. 178: 6814-6820.
30. Tscharke, D. C., G. Karupiah, J. Zhou, T. Palmore, K. R. Irvine, S. M. Haeryfar, S. Williams, J. Sidney, A. Sette, J. R. Bennink, and J. W. Yewdell. 2005. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201: 95-104.
31. Moutaftsi, M., B. Peters, V. Pasquetto, D. C. Tscharke, J. Sidney, H. H. Bui, H. Grey, and A. Sette. 2006. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol. 24: 817-819.
32. Davies, D. H., M. M. McCausland, C. Valdez, D. Huynh, J. E. Hernandez, Y. Mu, S. Hirst, L. Villarreal, P. L. Felgner, and S. Crotty. 2005. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 79: 11724-11733.
33. Moyron-Quiroz, J. E., M. M. McCausland, R. Kageyama, A. Sette, and S. Crotty. 2009. The smallpox vaccine induces an early neutralizing IgM response. Vaccine 28: 140-147.
34. Salek-Ardakani, S., Y. S. Choi, M. Rafii-El-Idrissi Benhnia, R. Flynn, R. Arens, S. Shoenberger, S. Crotty, M. Croft, and S. Salek-Ardakani. 2011. B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus. J. Immunol. 186: 5294-5303.
35. Schatz, D. G., and Y. Ji. 2011. Recombination centres and the orchestration of V (D)J recombination. Nat. Rev. Immunol. 11: 251-263.
36. Salek-Ardakani, S., R. Arens, R. Flynn, A. Sette, S. P. Schoenberger, and M. Croft. 2009. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J. Immunol. 182: 2909-2918.
37. Dimier, J., A. Ferrier-Rembert, K. Pradeau-Aubreton, M. Hebben, D. Spehner, A. L. Favier, D. Gratier, D. Garin, J. M. Crance, and R. Drillien. 2011. Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice. J. Virol. 85: 5016-5026.
38. Ober, B. T., P. Brühl, M. Schmidt, V. Wieser, W. Gritschenberger, S. Coulibaly, H. Savidis-Dacho, M. Gerencer, and F. G. Falkner. 2002. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara. J. Virol. 76: 7713-7723.
39. Karupiah, G., R. M. Buller, N. Van Rooijen, C. J. Duarte, and J. Chen. 1996. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70: 8301-8309.
40. Fang, M., and L. J. Sigal. 2005. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 175: 6829-6836.